REGEN-COV Monoclonal Antibody Treatment
What is the REGEN-COV Monoclonal Antibody?
REGEN-COV (Casirivimab/Imdevimab) is a monocolonal antibody treatment for COVID-19. Monoclonal antibodies aren't a new technology. They are laboratory-engineered molecules designed to neutralize the spike protein of COVID-19.
Who can get REGEN-COV Monoclonal Antibody?
The FDA has issued an Emergency Use Authorization to permit the use of REGEN-COV (Casirivimab/Imdevimab) for the treatment of mild to moderate COVID-19 in persons who meet ALL of the following conditions:
- Adults and pediatric patients (>12 years of age weighing >88 lbs)
- Positive COVID testing result
- Receive treatment within 10 days of symptom onset
- At high risk for progression to severe COVID-19 infection, including hospitalization or death
What qualifies as "high risk for progression to severe COVID-19 infection"?
High-risk groups include:
- >65 years of age
- Overweight (BMI >25)
- If age 12-17, BMI >85th% of their age and gender based on CDC4
- Chronic kidney disease
- Diabetes (Type 1 and Type 2)
- Immunosuppressive disease
- Currently receiving immunosuppressive treatment
- Cardiovascular disease/hypertension (high blood pressure)
- Chronic lung disease
- Sickle cell disease
- Neurodevelopmental disorders
- Medical-related technological dependence (for example, tracheostomy, gastrostomy, or CPAP [not related to COVID-19])
How do I get the REGEN-COV Monoclonal Antibody treatment?
Under the PREP Act, there are several ways you can become eligible for the REGEN-COV Monoclonal Antibody treatment:
- Your healthcare provider can issue an order for you to receive treatment.
- If your healthcare provider does not have our REGEN-COV order form, they can request the form by calling our store at 256-445-5400 or emailing firstname.lastname@example.org.
For more information on getting tested for COVID-19 infection, click here.
- How is REGEN-COV administered? The treatment is given as four injections under the skin. We do not give infusions.
- If my loved one is going to be admitted to the hospital, can they get the monoclonal antibody treatment? No. REGEN-COV only has an emergency use authorization for treatment of mild to moderate COVID-19 infection. If someone requires hospitalization, they have progressed to severe infection.
- I have had the COVID-19 vaccine. Can I still receive the monoclonal antibody treatment? Yes. Vaccination status is not considered when qualifying a patient for treatment.